Pediatric emergency medicine trisk 3020 3020

Loh NK, Lucas M, Fernandez S, et al. Successful treatment of macrophage activation
syndrome complicating adult Still disease with anakinra. Intern Med J
2012;42(12):1358–1362.
Marsh RA, Vaughn G, Kim MO, et al. Reduced-intensity conditioning significantly
improves survival of patients with hemophagocytic lymphohistiocytosis undergoing
allogeneic hematopoietic cell transplantation. Blood 2010;116(26):5824–5831.
Miettunen PM, Narendran A, Jayanthan A, et al. Successful treatment of severe
paediatric rheumatic disease-associated macrophage activation syndrome with
interleukin-1 inhibition following conventional immunosuppressive therapy: case
series with 12 patients. Rheumatology (Oxford) 2011;50(2):417–419.
Nagafuji K, Nonami A, Kumano T, et al. Perforin gene mutations in adult-onset
hemophagocytic lymphohistiocytosis. Haematologica 2007;92(7):978–981.
Ravelli A, Grom AA, Behrens EM, et al. Macrophage activation syndrome as part of
systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and
treatment. Genes Immun 2012;13(4): 289–298.
Risma K, Jordan MB. Hemophagocytic lymphohistiocytosis: updates and evolving
concepts. Curr Opin Pediatr 2012;24(1):9–15.
Vasculitis/Polyarteritis Nodosa
Dedeoglu F, Sundel RP. Vasculitis in children. Pediatr Clin North Am 2005;52:547–
575.
Fink CW. Vasculitis. Pediatr Clin North Am 1986;33:1203–1219.
Gunal N, Kara N, Cakar N, et al. Cardiac involvement in childhood polyarteritis
nodosa. Int J Cardiol 1997;60:257–262.
Sundel R, Szer I. Vasculitis in childhood. Rheum Dis Clin North Am 2002;28:625–654.
Ting TV, Hashkes PJ. Update on childhood vasculitides. Curr Opin Rheumatol
2004;16:560–565.
Kawasaki Disease
American Academy of Pediatrics. Kawasaki disease. In: Pickering LK, Baker CJ,
Kimberlin DW, et al., eds. Red Book: 2012 Report of the Committee on Infectious
Diseases . 29th ed. Elk Grove Village, IL: American Academy of Pediatrics;
2012:454–460.

Dimitriades VR, Brown AG, Gedalia A. Kawasaki disease: pathophysiology, clinical
manifestations and management. Curr Rheumatol Rep 2014;16:423.
Dionne A, Burns J, Dahdah N, et al. Treatment intensification in patients with
Kawasaki disease and coronary aneurysm at diagnosis. Pediatrics
2019;143(6):e20183341.
Hedrich CM, Schnabel A, Hospach T. Kawasaki Disease. Front Pediatr 2018;6:198.
Kanegaye JT, Wilder MS, Molkara D, et al. Recognition of a Kawasaki disease shock
syndrome. Pediatrics 2009;123:e783.